Background Recent pandemics, epidemics and outbreaks continually underscore the critical importance of resilient supply chains in healthcare, particularly in clinical laboratories where timely access to supplies is essential for patient care. Supply chain disruptions, whether due to global crises or localized challenges, can significantly impact laboratory operations, leading to delayed diagnoses, compromised patient outcomes, and increased costs. It is estimated that 70%-80% of a patients’ EMR is clinical laboratory results. Despite this, supply chain resilience in clinical laboratories remains an under-addressed issue and remains a buzzword. Methods To evaluate the cost and importance of supply chain resilience in the clinical laboratory, we conducted a comprehensive review and interviews with 9 Healthcare Supply Chain experts analyzing the impact of supply chain disruptions on laboratory operations and patient care. Data was also collected from a diverse range of clinical laboratories, including hospitals, independent labs, and research institutions, spanning different geographic regions as well as a survey of 50 Laboratory experts with a 50% response rate. Key metrics assessed included: -Frequency and duration of supply chain disruptions. -Financial costs incurred due to disruptions, including expenses related to expedited shipping, alternative sourcing, and inventory management. -Impact on laboratory workflow, turnaround times, and patient care outcomes. -Strategies employed to mitigate supply chain risks and enhance resilience. Results Our review revealed findings regarding the cost and importance of supply chain resilience in the clinical laboratory: -Supply chain disruptions were frequent, with 85% of laboratories experiencing at least one significant disruption in the past year and 100% in experienced disruptions 2022. -The average duration of disruptions was 2-3 weeks, leading to substantial delays in test processing and patient care. -Financial costs associated with disruptions averaged $50,000 per laboratory per annum, including expenses for rush orders, and premium-priced alternatives. -Common strategies employed were increased inventory or safety stocks, multi-vendor sourcing, and supply chain mapping. Conclusions The findings of this study underscore the critical importance of supply chain resilience in the clinical laboratory. Supply chain disruptions are not just inconveniences; they pose significant risks to patient safety, operational efficiency, and financial sustainability. Investing in supply chain resilience is imperative for laboratories to fulfill their mission of delivering timely and accurate patient results. To continue to enhance supply chain resilience, laboratories must adopt a proactive approach, leveraging data-driven insights and collaborative partnerships. This includes diversifying supplier networks and fostering closer collaboration between laboratory and procurement teams.

中文翻译：

---

A-205 评估临床实验室供应链弹性的成本和重要性


背景 最近的流行病、流行病和爆发不断强调了弹性供应链在医疗保健领域的至关重要性，特别是在临床实验室中，及时获得供应​​对于患者护理至关重要。供应链中断，无论是由于全球危机还是局部挑战，都会严重影响实验室运营，导致诊断延迟、患者治疗结果受损和成本增加。据估计，患者 EMR 的 70%-80% 是临床实验室结果。尽管如此，临床实验室的供应链弹性仍然是一个未得到充分解决的问题，并且仍然是一个流行词。方法 为了评估临床实验室供应链弹性的成本和重要性，我们对 9 名医疗保健供应链专家进行了全面审查和访谈，分析了供应链中断对实验室运营和患者护理的影响。数据还从跨越不同地理区域的各种临床实验室（包括医院、独立实验室和研究机构）收集，并对 50 名实验室专家进行了调查，答复率为 50%。评估的关键指标包括： -供应链中断的频率和持续时间。 - 由于中断而产生的财务成本，包括与加急运输、替代采购和库存管理相关的费用。 -对实验室工作流程、周转时间和患者护理结果的影响。 - 用于减轻供应链风险和增强弹性的策略。 结果 我们的审查揭示了有关临床实验室供应链弹性的成本和重要性的调查结果： - 供应链中断很频繁，85% 的实验室在过去一年中至少经历过一次重大中断，100% 的实验室在 2022 年经历过中断。 -中断的平均持续时间为 2-3 周，导致测试处理和患者护理出现严重延误。 - 每个实验室每年与中断相关的财务成本平均为 50,000 美元，包括紧急订单和高价替代品的费用。 - 采用的常见策略是增加库存或安全库存、多供应商采购和供应链映射。结论 这项研究的结果强调了临床实验室供应链弹性的至关重要性。供应链中断不仅带来不便；它们对患者安全、运营效率和财务可持续性构成重大风险。对于实验室履行提供及时、准确的患者结果的使命而言，投资供应链弹性至关重要。为了继续增强供应链的弹性，实验室必须采取积极主动的方法，利用数据驱动的见解和合作伙伴关系。这包括供应商网络多元化以及促进实验室和采购团队之间更密切的合作。